THE PANCREATIC CANCER ACTION NETWORK, along with advocates and survivors, gathered on Capitol Hill this week to urge Congress to fund federal cancer research. “To ensure Congress continues to make cancer research funding a priority, we need even more committed individuals to join our efforts,” said Julie Fleshman, president and CEO of the Pancreatic Cancer...
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
